NECA in the Know artwork

NECA in the Know

194 episodes - English - Latest episode: 2 days ago - ★★★★★ - 4 ratings

A podcast for healthcare providers in the HIV field.

Medicine Health & Fitness
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Episodes

Episode 63: COVID-19 & HIV Care

June 30, 2022 05:00 - 13 minutes - 9.31 MB

This week, we're sitting down with John Faragon to talk about the impact of the COVID-19 pandemic on HIV testing, diagnosis, and linkage to care. Join us as we explore these topics and assess surveillance data that the CDC collected in 2020.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=JUS3692)

Episode 62: Lenacapavir Off Hold - Now What?

June 23, 2022 05:00 - 10 minutes - 7.33 MB

This week, we sit down with John Faragon to discuss the clinical hold that's been lifted for lenacapavir - a drug used for HIV treatment. Now that the hold has been lifted, what's next? Tune in to learn all about what lenacapavir is, who it's for, and why HIV providers should be interested in this news.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=VTV3934) Want to chat? Email us at [email protected] with comment...

Episode 62: Lenacapavir Off Hold - Now What?

June 23, 2022 05:00 - 10 minutes - 7.33 MB

This week, we sit down with John Faragon to discuss the clinical hold that's been lifted for lenacapavir - a drug used for HIV treatment. Now that the hold has been lifted, what's next? Tune in to learn all about what lenacapavir is, who it's for, and why HIV providers should be interested in this news.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=VTV3934)

Episode 61: Paxlovid Failures

June 16, 2022 05:00 - 18 minutes - 12.9 MB

This week, we sat down with John Faragon to talk about a common drug for treating COVID-19 – nirmatrelvir with ritonavir or more widely known as Paxlovid. What is it? Who is it for? And, most importantly, why has it been failing?  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=CUV3933)  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaae...

Episode 60: All About INSTIs

June 09, 2022 05:00 - 19 minutes - 13.3 MB

This week, we're sitting down with John Faragon to discuss the use of integrase strand transfer inhibitors - or INSTIs - in treatment experienced patients. Learn all about what they are, the latest studies, and why it all matters.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=SDL3637)  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.neca...

Episode 59: Why is Islatravir On Hold?

June 02, 2022 05:00 - 16 minutes - 11.2 MB

This week, we're sitting down with John Faragon to talk all things Islatravir -- What is it? Who is it for? Why has it been put on hold? Why is this important for HIV providers? Learn all of this and more on this episode of NECA in the Know.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=VRG3607) 

Episode 59: Why is Islatravir On Hold?

June 02, 2022 05:00 - 16 minutes - 11.2 MB

This week, we're sitting down with John Faragon to talk all things Islatravir -- What is it? Who is it for? Why has it been put on hold? Why is this important for HIV providers? Learn all of this and more on this episode of NECA in the Know.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=VRG3607)  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online course...

Episode 58: HIV & Mental Health

May 26, 2022 05:00 - 25 minutes - 17.6 MB

This week, we're sitting down with John Faragon for Mental Health Awareness Month to discuss mental health and HIV in the United States, drug interactions for medications providers often prescribe for mental health conditions, and much more.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=KER3589) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses...

Episode 57: HIV & Pregnancy

May 19, 2022 05:00 - 11 minutes - 8 MB

This week, Marianna sits down with John Faragon for a quick update on recent guidelines relating to people who are pregnant and living with HIV. Find out how their treatment differs from others, all about various drug regimens, and more.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=UMW3568) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: ww...

Episode 56: COVID-19 Vaccine Update

May 12, 2022 05:00 - 15 minutes - 10.9 MB

This week, we're sitting down with John Faragon to talk about the latest in COVID-19 vaccine information. Tune in to learn about what's going on with the Johnson & Johnson vaccine, how many doses people need to be considered fully vaccinated, and more.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=PFY3556) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free onl...

Episode 55: CROI 2022 Update (Part 2)

May 05, 2022 05:00 - 18 minutes - 12.5 MB

This week, we're sitting down with John Faragon for the second part of our series on the CROI 2022 conference. Find out about some of the latest HIV studies, medications, and advancements from this year's event.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=VXK3426) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-course...

Episode 54: Spring COVID-19 Update

April 28, 2022 05:00 - 20 minutes - 13.9 MB

This week, we're sitting down with John Faragon to get an update on the latest regarding the ever-changing COVID-19 pandemic. Where do we stand now in terms of cases, recommendations on masking, vaccination, and more? Tune in to find out.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=KTX3436) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: w...

Episode 53: CROI 2022 Update (Part 1)

April 21, 2022 05:00 - 19 minutes - 13.6 MB

This week, we're sitting down with John Faragon for part one of our two-part series on the CROI 2022 conference. Find out what this conference is, why it's so important for HIV providers, and everything that was covered this year.   -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=CLN3405)

Episode 53: CROI 2022 Update (Part 1)

April 21, 2022 05:00 - 19 minutes - 13.6 MB

This week, we're sitting down with John Faragon for part one of our two-part series on the CROI 2022 conference. Find out what this conference is, why it's so important for HIV providers, and everything that was covered this year.   -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=CLN3405) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.neca...

Episode 52: Transgender & Gender Non-Binary Patient Care

April 14, 2022 05:00 - 14 minutes - 9.7 MB

This week, we're talking to Dr. Carrie Johnston about transgender and gender non-binary patient care. Find out everything you need to know to form a therapeutic alliance with transgender & gender non-binary patients, and more.  -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=XDV3324) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc....

Episode 51: Diagnostic COVID-19 Testing

April 07, 2022 05:00 - 18 minutes - 13 MB

This week, we're sitting down with John Faragon to talk about diagnostic testing for SARS-CoV2, or COVID-19. Learn more about how to determine when to test, which test to use, and why it all matters. -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=ARU3323) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download o...

Episode 50: Outpatient COVID-19 Treatment

March 31, 2022 05:00 - 14 minutes - 9.85 MB

This week, we're sitting down with John Faragon to talk about the NIH guidelines for outpatient management of COVID-19. -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=GOJ3322) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download our HIV mobile apps: Google Play Store: https://play.google.com/store/apps/devel...

Episode 49: A New HIV Variant?

March 24, 2022 05:00 - 10 minutes - 7.35 MB

This week, we sit down with John Faragon to discuss a new HIV variant  - what it is, how it came about, and what it means. -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=YQL3307)

Episode 49: A New HIV Variant?

March 24, 2022 05:00 - 10 minutes - 7.35 MB

This week, we sit down with John Faragon to discuss a new HIV variant  - what it is, how it came about, and what it means. -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=YQL3307) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download our HIV mobile apps: Google Play Store: https://play.google.com/store/apps/de...

Episode 48: Cabotegravir & HIV Prevention

March 17, 2022 05:00 - 13 minutes - 9.43 MB

This week, we sat down with John Faragon to talk about the approval to use cabotegravir for HIV prevention. Learn all about this injection, who it's for, and how it can be used for pre-exposure prophylaxis or PrEP. -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=XWJ3277) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-cour...

Episode 47: Treatment Failure & Resistance

March 10, 2022 06:00 - 17 minutes - 12 MB

This week, we’re sitting down with John Faragon to talk a little bit about anti-retroviral therapy for folks with a history of treatment failure and resistance. -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=PJE3264) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download our HIV mobile apps: Google Play Store:...

Episode 46: An HIV Vaccine?

March 03, 2022 06:00 - 25 minutes - 17.5 MB

This week, we’re sitting down with Dr. Marshall Glesby to talk a little bit an exciting advancement in HIV medicine – a new clinical trial for an HIV vaccine using mRNA technology. -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=FQC3210) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download our HIV mobile apps:...

Episode 45: The ANCHOR Study

February 24, 2022 06:00 - 17 minutes - 12 MB

This week, we're sitting down with Dr. Grant Ellsworth to talk about a recent study regarding prevention of anal cancer and why it’s important for people living with HIV. -- Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=CFC3186) Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download our HIV mobile apps: Google P...

Special Edition: An HIV Cure?

February 16, 2022 15:00 - 15 minutes - 11 MB

Today, we’re sitting down with Dr. Marshall Glesby for a special edition episode to talk about an exciting advancement in HIV medicine – a third person has achieved long-term remission of HIV by means of a stem cell transplant. Learn about how his team contributed to this study and what this means for the future of HIV medicine. -- Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=HHM3163)  Want to chat? Email us at podcast...

Special Edition: An HIV Cure?

February 16, 2022 15:00 - 15 minutes - 11 MB

Today, we’re sitting down with Dr. Marshall Glesby for a special edition episode to talk about an exciting advancement in HIV medicine – a third person has achieved long-term remission of HIV by means of a stem cell transplant. Learn about how his team contributed to this study and what this means for the future of HIV medicine. -- Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=HHM3163) 

Episode 44: Monoclonal Antibodies & Omicron

February 10, 2022 06:00 - 15 minutes - 10.7 MB

This week, we're chatting with John Faragon about the role of monoclonal antibodies in the omicron variant of COVID-19.  Find out how they can help not only fight against the virus, but prevent folks from getting infected, and who would benefit most from this treatment. -- Help us track the number of listeners our episode gets by filling out this brief form!   Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.n...

Episode 43: New HIV Mobile Apps

February 03, 2022 06:00 - 15 minutes - 10.4 MB

This week on NECA in the Know, we're introducing four new mobile apps for drug interactions that John Faragon has developed with NECA AETC. Learn all about what they are, who they're for, how they work, and more. Download all four apps from the Google Play Store (https://cutt.ly/lOEy9iP) or the Apple App Store (https://cutt.ly/5PSFFHq) today. -- Help us track the number of listeners our episode gets by filling out this brief form!   Want to chat? Email us at [email protected] with co...

Episode 42: Paxlovid Revisited

January 27, 2022 06:00 - 17 minutes - 12.2 MB

This week,  we’re sitting down with John Faragon to talk a little more about Paxlovid – a drug used to treat COVID-19. We dive into what exactly it is, how providers should prescribe it, and more. -- Help us track the number of listeners our episode gets by filling out this brief form!   Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download our HIV mobile apps: Google Play Store...

Episode 41: Helping Treatment Experienced Patients

January 20, 2022 06:00 - 14 minutes - 9.85 MB

This week, we're back with John Faragon to break down the use of lenacapavir for HIV infection. Find out what this medication is, who it's for, and how it can help treatment experienced patients. -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download our HIV mobile apps: Google Play Store: ...

Episode 40: What are Islatravir & Doravirine?

January 13, 2022 06:00 - 9 minutes - 6.82 MB

This week we're back for a quick round-up with John Faragon to talk about the use of two medications to treat HIV – islatravir and doravirine. Find out what they are, what they do, and how they can help you as a provider improve treatment for PLWH. -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-course...

Episode 40: What are Islatravir & Doravirine?

January 13, 2022 06:00 - 9 minutes - 6.82 MB

This week we're back for a quick round-up with John Faragon to talk about the use of two medications to treat HIV – islatravir and doravirine. Find out what they are, what they do, and how they can help you as a provider improve treatment for PLWH. -- Help us track the number of listeners our episode gets by filling out this brief form! 

Episode 39: HIV in the U.S.

January 06, 2022 06:00 - 19 minutes - 13.6 MB

Happy New Year! We're kicking off our 2022 podcast season with an update on HIV stats from the CDC. We break it all down with John Faragon so that you as providers can know what these new numbers mean and how they affect PLWH. -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download our HIV mo...

Episode 39: HIV in the U.S.

January 06, 2022 06:00 - 19 minutes - 13.6 MB

Happy New Year! We're kicking off our 2022 podcast season with an update on HIV stats from the CDC. We break it all down with John Faragon so that you as providers can know what these new numbers mean and how they affect PLWH. -- Help us track the number of listeners our episode gets by filling out this brief form! 

Mixing & Matching Boosters (Ep. 35 Rebroadcast)

December 30, 2021 05:00 - 17 minutes - 12 MB

In this episode, Marianna & John discuss a crucial topic in the COVID-19 pandemic saga - mixing & matching COVID-19 vaccine booster shots. Is it recommended? Is it safe? Listen to learn all this and more. -- Help us track the number of listeners our episode gets by filling out this brief form! 

Mixing & Matching Boosters (Ep. 35 Rebroadcast)

December 30, 2021 05:00 - 17 minutes - 12 MB

In this episode, Marianna & John discuss a crucial topic in the COVID-19 pandemic saga - mixing & matching COVID-19 vaccine booster shots. Is it recommended? Is it safe? Listen to learn all this and more. -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download our HIV mobile apps: Google Pla...

Episode 38: The EHE Program with Catherine Farquharson

December 23, 2021 06:00 - 21 minutes - 14.5 MB

This week, we're talking about NECA AETC's impact on the Ending the HIV Epidemic (EHE) Program with the center's very own Catherine Farquharson. Find out all about her role at NECA AETC, how she's helping the center tackle some of the EHE goals, and more.  -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/ris...

Episode 37: What is Paxlovid?

December 16, 2021 06:00 - 12 minutes - 8.39 MB

This week on the podcast, we’re back with John Faragon to talk about Paxlovid – an oral antiviral treatment from Pfizer for COVID-19. Find out what it is, who it's for, how it was developed, and more. -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download our HIV mobile apps: Google Play St...

Special Edition: COVID-19 Omicron Variant

December 09, 2021 06:00 - 18 minutes - 12.9 MB

This week, John Faragon sits down with us for a special edition episode all about the latest COVID-19 variant - Omicron. Learn about what it is, when it was first discovered, who is at risk, and more. -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download our HIV mobile apps: Google Play St...

Episode 36: What is Fostemsavir?

December 02, 2021 06:00 - 11 minutes - 7.81 MB

This week, we're back from our Thanksgiving break to talk all things fostemsavir, a new HIV medication. What is it? Who is it for? What do providers need to know? John Faragon breaks it all down for us, so listen to learn all this and more. -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Down...

Episode 36: What is Fostemsavir?

December 02, 2021 06:00 - 11 minutes - 7.81 MB

This week, we're back from our Thanksgiving break to talk all things fostemsavir, a new HIV medication. What is it? Who is it for? What do providers need to know? John Faragon breaks it all down for us, so listen to learn all this and more. -- Help us track the number of listeners our episode gets by filling out this brief form! 

Episode 35: Mixing & Matching COVID-19 Boosters

November 18, 2021 06:00 - 17 minutes - 12 MB

This week, we're sitting down with John Faragon to discuss a hot topic in the COVID-19 pandemic saga - mixing & matching COVID-19 vaccine booster shots. Is it recommended? Is it safe? Listen to learn all this and more. -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download our HIV mobile a...

Episode 34: Weight Gain & HIV Medications

November 11, 2021 06:00 - 16 minutes - 11.1 MB

This week, we're talking to John Faragon about the side effect of weight gain as a result of certain HIV medications. Find out which medications to look out for, what providers are seeing in some patients, and the guidance to address this.   -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Downlo...

Episode 33: What is Molnupiravir?

November 04, 2021 05:00 - 11 minutes - 7.6 MB

This week, we're sitting down with John Faragon to talk all things Molnupiravir. Find out what this new investigational medication for COVID-19 is, who it's for, and what it means for the ongoing pandemic. -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download our HIV mobile apps: Google Pl...

Episode 33: What is Molnupiravir?

November 04, 2021 05:00 - 11 minutes - 7.6 MB

This week, we're sitting down with John Faragon to talk all things Molnupiravir. Find out what this new investigational medication for COVID-19 is, who it's for, and what it means for the ongoing pandemic. -- Help us track the number of listeners our episode gets by filling out this brief form! 

Episode 32: Pfizer Vaccine for Children Ages 5-11

October 28, 2021 05:00 - 15 minutes - 10.3 MB

This week, we're talking to John Faragon about the approval process for the COVID-19 Pfizer vaccine for children between the ages of 5 and 11. Where does Pfizer stand in getting approval for this vaccine? How was the trial conducted? What are the risk factors? Learn all this and more. -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online ...

Special Edition: COVID-19 Mu Variant

October 21, 2021 05:00 - 15 minutes - 10.4 MB

This week we're sitting down with John Faragon for a special edition episode about a new, emerging variant of the COVID-19 virus - the Mu variant. Find out what it is, who is at risk, how to stay safe, and what providers need to know. -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/rise-courses Download ou...

Episode 31: CopeColumbia

October 14, 2021 05:00 - 24 minutes - 17 MB

This week, we're sitting down with Claude Mellins and Bob Remien to talk all things CopeColumbia - a peer support wellbeing program here at Columbia University. Learn about what it is, who it's for, and how you can get involved. Learn more about CopeColumbia here. -- Help us track the number of listeners our episode gets by filling out this brief form! 

Episode 31: CopeColumbia

October 14, 2021 05:00 - 24 minutes - 17 MB

This week, we're sitting down with Claude Mellins and Bob Remien to talk all things CopeColumbia - a peer support wellbeing program here at Columbia University. Learn about what it is, who it's for, and how you can get involved. Learn more about CopeColumbia here. -- Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaae...

Episode 30: CASIINDEV & COVID-19

October 07, 2021 05:00 - 16 minutes - 11.6 MB

This week we sat down with John Faragon to talk about the use of casirivimab and imdevimab as post-exposure prevention of COVID-19. Learn about who would benefit from this drug combination, when to administer it, and everything healthcare providers need to know. Help us track the number of listeners our episode gets by filling out this brief form! 

Episode 30: CASIINDEV & COVID-19

October 07, 2021 05:00 - 16 minutes - 11.6 MB

This week we sat down with John Faragon to talk about the use of casirivimab and imdevimab as post-exposure prevention of COVID-19. Learn about who would benefit from this drug combination, when to administer it, and everything healthcare providers need to know. Help us track the number of listeners our episode gets by filling out this brief form!  Want to chat? Email us at [email protected] with comments or ideas for new episodes. Check out our free online courses: www.necaaetc.org/...